Atlas Trials

Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection - Phase II Clinical Trial

Clinical trial NCT06193733 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06193733
Sponsor
Chang Gung Memorial Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-07-01
Primary completion
2028-02-01
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.